uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
Go back to uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease| UNIQURE (NASDAQ: QURE) | Delayed: 44.87 +0.36 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.51 | 52 Week High | $22.79 | |||
| Open | $44.27 | 52 Week Low | $6.63 | |||
| Day High | $45.75 | P/E | N/A | |||
| Day Low | $44.05 | EPS | $0.00 | |||
| Volume | 323,191 | |||||

